Intraparenchymal Hemorrhage

Patient presents with acute onset of [symptom descriptor, e.g., headache, focal neurological deficit, altered mental status] consistent with suspected intraparenchymal hemorrhage.  Onset of symptoms occurred [timeframe] prior to presentation.  Patient reports [associated symptoms, e.g., nausea, vomiting, dizziness].  Past medical history significant for [relevant comorbidities, e.g., hypertension, cerebral amyloid angiopathy, coagulopathy, prior stroke].  Medications include [list current medications].  Family history includes [relevant family history, e.g., stroke, bleeding disorders].  Physical examination reveals [neurological findings, e.g., hemiparesis, sensory loss, aphasia, anisocoria, decreased level of consciousness, Glasgow Coma Scale score of [score]].  Differential diagnosis includes intracerebral hemorrhage, subdural hematoma, epidural hematoma, ischemic stroke, transient ischemic attack.  Initial imaging with [imaging modality, e.g., non-contrast CT scan of the head] demonstrates [imaging findings, e.g., a hyperdense focus consistent with acute intraparenchymal hemorrhage located within the [location, e.g., basal ganglia, cerebellum, frontal lobe], measuring [dimensions]).  Hemorrhage volume is estimated to be [volume].  Evidence of [associated findings, e.g., surrounding edema, mass effect, midline shift].  Neurological consultation obtained.  Treatment plan includes [management strategies, e.g., blood pressure management, reversal of anticoagulation if applicable, neurosurgical evaluation, intensive care unit admission, supportive care].  Patient's condition is currently [status, e.g., stable, critical, improving].  Prognosis guarded given the location and size of the hemorrhage.  Continued monitoring for neurological deterioration and complications such as cerebral edema and herniation.  ICD-10 code I61.x assigned.  Further evaluation and management based on clinical evolution.